We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions


Six years after the Affordable Care Act cleared the way for biosimilars, as the generic versions of biotechnology drugs are called, progress has been slow.
read more

Source: NY Times


23:45, July 15, 2016 ANDREW POLLACK

News